Clinical Trial Update: Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by Cardiac Dysfunction [Phase 4]

View source ↗

Summary

Phase 4 trials are ongoing to evaluate the efficacy and safety of Yangxinshi Tablets in patients with coronary heart disease complicated by heart failure, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Heart Failure

Drugs mentioned

• Yangxinshi Tablets

Snippet

Sponsor: SPH Qingdao Growful Pharmacetical Co.,Ltd | Conditions: Coronary Heart Disease, Cardiac Dysfunction | Phase 4 | Status: RECRUITING